blinatumomab
amgen
['aall1331', 'blinatumomab']
children's oncology group aall1331: phase iii trial of blinatumomab in children, adolescents, and young adults with low-risk b-cell all in first relapse #asco23 #asco2023 
Biomedical Science that Inspires. #medicine #medtwitter #meded #Science #Research #Technology #News